The rising level of long-term care (LTC) expenditures and their financing sources are likely to impact savings and capital accumulation and henceforth the pattern of growth.
SCOR announces the creation of a local entity in Brazil, SCOR Brasil Resseguros SA (SCOR Brasil Re), following the licence to operate as a Local Reinsurer granted by the Brazilian insurance authority SUSEP on 26 Augus
Fitch has raised to “positive” the outlook on the ’A+’ rating of SCOR SE and its main subsidiaries.
SCOR's first half of 2014 results.
SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013
SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013
Details about the liquidity account at 30 june 2014 and of the last half-year statement
Lupus is a disease caused by a disorder of the immune system. Its pathophysiological mechanisms, which include genetic, immunological and environmental factors, remain poorly understood. This is a rare disease.
NUOVI ASPETTI DEL LES (LUPUS ERITEMATOSO SISTEMICO) Il lupus è una patologia legata ad un disturbo immunitario.
NUEVOS ENFOQUES DEL LED (LUPUS ERITEMATOSO DISEMINADO) El lupus es una patología asociada a un pro blema inmunitario.
The new Cologne-Zurich Hub will maintain the existing two locations of Cologne and Zurich, under a single management team.
The Trading Risk Awards ceremony is held each year to acknowledge the hard work and professionalism of the (re)insurance convergence market.
